These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20455190)

  • 21. Accidental intracerebroventricular injection of anaesthetic drugs during induction of general anaesthesia.
    Tiefenthaler W; Tschupik K; Hohlrieder M; Eisner W; Benzer A
    Anaesthesia; 2006 Dec; 61(12):1208-10. PubMed ID: 17090244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fast-track anesthesia in patients undergoing outpatient laparoscopic cholecystectomy: comparison of sevoflurane with total intravenous anesthesia.
    Çaparlar CÖ; Özhan MÖ; Süzer MA; Yazicioğlu D; Eşkin MB; Şenkal S; Çaparlar MA; Imren EÖ; Atik B; Çekmen N
    J Clin Anesth; 2017 Feb; 37():25-30. PubMed ID: 28235523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A review of anaesthetic outcomes in patients with genetically confirmed mitochondrial disorders.
    Smith A; Dunne E; Mannion M; O'Connor C; Knerr I; Monavari AA; Hughes J; Eustace N; Crushell E
    Eur J Pediatr; 2017 Jan; 176(1):83-88. PubMed ID: 27885500
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Masseter spasm after induction of general anaesthesia using propofol and remifentanil.
    Wetsch WA; Böttiger BW; Padosch SA
    Eur J Anaesthesiol; 2010 Dec; 27(12):1069-70. PubMed ID: 20657298
    [No Abstract]   [Full Text] [Related]  

  • 25. MAO-B inhibitors in Parkinson's disease.
    Olanow CW
    Adv Neurol; 1993; 60():666-71. PubMed ID: 8420207
    [No Abstract]   [Full Text] [Related]  

  • 26. Monoamine oxidase-B inhibition in the treatment of Parkinson's disease.
    Fernandez HH; Chen JJ
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):174S-185S. PubMed ID: 18041937
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sufentanil-propofol vs remifentanil-propofol during total intravenous anesthesia for neurosurgery. A multicentre study.
    Martorano PP; Aloj F; Baietta S; Fiorelli A; Munari M; Paccagnella F; Rosa G; Scafuro M; Zei E; Falzetti G; Pelaia P
    Minerva Anestesiol; 2008 Jun; 74(6):233-43. PubMed ID: 18414368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of predosing versus slow administration of propofol on the dose required for anaesthetic induction and on physiologic variables in healthy dogs.
    Raillard M; Love EJ; Murison PJ
    Vet Anaesth Analg; 2018 Jul; 45(4):414-422. PubMed ID: 29661678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternatives to levodopa in the initial treatment of early Parkinson's disease.
    Lees A
    Drugs Aging; 2005; 22(9):731-40. PubMed ID: 16156677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A multicentre, randomised, open-label, controlled trial evaluating equivalence of inhalational and intravenous anaesthesia during elective craniotomy.
    Citerio G; Pesenti A; Latini R; Masson S; Barlera S; Gaspari F; Franzosi MG;
    Eur J Anaesthesiol; 2012 Aug; 29(8):371-9. PubMed ID: 22569025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Speed of induction of anaesthesia in dogs administered halothane, isoflurane, sevoflurane or propofol in a clinical setting.
    Pottie RG; Dart CM; Perkins NR
    Aust Vet J; 2008; 86(1-2):26-31. PubMed ID: 18271820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Remifentanil in heart surgery].
    Bonome C
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):476-80. PubMed ID: 11792305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical use of xenon in 2 elderly patients.
    Cattano D; Forfori F; Giunta F
    J Neurosurg Anesthesiol; 2008 Apr; 20(2):156-8. PubMed ID: 18362786
    [No Abstract]   [Full Text] [Related]  

  • 34. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2005 Jun; (13):1658-77. PubMed ID: 16135305
    [No Abstract]   [Full Text] [Related]  

  • 35. Other pharmacological treatments for motor complications and dyskinesias.
    Waters C
    Mov Disord; 2005; 20 Suppl 11():S38-44. PubMed ID: 15822104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of MAO inhibition in Parkinson's disease.
    Knoll J
    Adv Neurol; 1987; 45():107-10. PubMed ID: 3103382
    [No Abstract]   [Full Text] [Related]  

  • 37. A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.
    Clarke A; Johnson ES; Mallard N; Corn TH; Johnston A; Boyce M; Warrington S; MacMahon DG
    J Neural Transm (Vienna); 2003 Nov; 110(11):1257-71. PubMed ID: 14628190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No supplemental muscle relaxants are required during propofol and remifentanil total intravenous anesthesia for laparoscopic pelvic surgery.
    Paek CM; Yi JW; Lee BJ; Kang JM
    J Laparoendosc Adv Surg Tech A; 2009 Feb; 19(1):33-7. PubMed ID: 19226229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinson's disease: drug therapy.
    Oertel WH; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's disease.
    Clarke C; Moore AP
    Clin Evid; 2003 Dec; (10):1582-98. PubMed ID: 15555162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.